Sándor Benyhe Selected Research

Sándor Benyhe Research Topics

Disease

11	Pain (Aches) 04/2023 - 06/2004
5	Schizophrenia (Dementia Praecox) 12/2020 - 04/2016
4	Hyperalgesia 04/2023 - 06/2004
3	Inflammation (Inflammations) 01/2023 - 05/2009
2	Neuralgia (Stump Neuralgia) 04/2023 - 01/2019
2	Premature Birth (Birth, Premature) 11/2022 - 06/2016
2	Epilepsy (Aura) 07/2017 - 03/2012
2	Chronic Pain 12/2016 - 10/2016
2	Tics (Tic) 01/2007 - 01/2005
1	Substance-Related Disorders (Drug Abuse) 11/2023
1	Neuroinflammatory Diseases 01/2023
1	Pathologic Processes 01/2023
1	Necrosis 01/2023
1	Edema (Dropsy) 01/2022
1	Pancreatitis 01/2022
1	Disease Progression 01/2022
1	Dysbiosis 05/2020
1	Constipation 03/2020
1	Opioid-Related Disorders (Opiate Addiction) 12/2019
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 12/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019
1	Nervous System Diseases (Neurological Disorders) 07/2017
1	Psychotic Disorders (Schizoaffective Disorder) 07/2017
1	Migraine Disorders (Migraine) 07/2017
1	Hypothermia 06/2016
1	Mental Disorders (Mental Disorder) 02/2014
1	Seizures (Absence Seizure) 03/2012
1	Catatonia 05/2002

Drug/Important Bio-Agent (IBA)

11	Opioid Analgesics (Opioids)IBA 04/2023 - 06/2004
4	Morphine (MS Contin)FDA LinkGeneric 04/2023 - 12/2019
4	Analgesics (Analgesic Drugs)IBA 04/2023 - 10/2016
4	CannabinoidsIBA 05/2021 - 03/2012
3	Opiate AlkaloidsIBA 11/2023 - 07/2005
3	GTP-Binding Proteins (G-Protein)IBA 12/2020 - 03/2012
2	Peptides (Polypeptides)IBA 01/2023 - 01/2005
2	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 12/2016
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2020 - 03/2012
2	EndocannabinoidsIBA 10/2019 - 07/2017
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 02/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2016 - 06/2004
2	tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA 01/2007 - 01/2005
1	Losartan (Cozaar)FDA LinkGeneric 04/2023
1	Telmisartan (Micardis)FDA Link 04/2023
1	Glutamic Acid (Glutamate)FDA Link 04/2023
1	CytokinesIBA 01/2023
1	cocaine- and amphetamine-regulated transcript protein (55-102)IBA 01/2023
1	Toll-Like Receptor 4IBA 01/2023
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2023
1	CarrageenanIBA 01/2023
1	Cocaine (Cocaine HCl)IBA 01/2023
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2023
1	Isoleucine (L-Isoleucine)FDA Link 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Proline (L-Proline)FDA Link 01/2023
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2020
1	Dopamine (Intropin)FDA LinkGeneric 12/2020
1	Freund's AdjuvantIBA 03/2020
1	Codeine (Codeine Phosphate)FDA LinkGeneric 03/2020
1	Naloxone (Narcan)FDA LinkGeneric 12/2019
1	KynurenineIBA 07/2017
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2017
1	N-Methylaspartate (NMDA)IBA 07/2017
1	Kynurenic Acid (Kynurenate)IBA 07/2017
1	Progesterone FDA LinkGeneric 06/2016
1	Kainic Acid (Kainate)IBA 03/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2008
1	SR 144528IBA 12/2008
1	Cannabinoid Receptor AntagonistsIBA 12/2008
1	Xenopus Xen-dorphin prohormoneIBA 03/2007
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2007
1	Carboxylic AcidsIBA 01/2007
1	Amino Acids FDA Link 01/2007
1	1,2,3,4-tetrahydroisoquinolineIBA 01/2007
1	Opioid Peptides (Opioid Peptide)IBA 01/2007
1	cyclohexylalanineIBA 01/2007
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 07/2005
1	AcidsIBA 01/2005
1	hydroxide ionIBA 01/2005
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2005
1	phenylalanylphenylalanineIBA 01/2005
1	Guanosine 5'-O-(3-Thiotriphosphate)IBA 10/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2004
1	Methionine EnkephalinIBA 06/2004
1	Dynorphins (Dynorphin)IBA 06/2004
1	NociceptinIBA 06/2004
1	zeta receptorIBA 06/2004
1	Narcotics (Narcotic Analgesics)IBA 05/2002
1	Etorphine (M99)IBA 05/2002

Therapy/Procedure

3	Analgesia 01/2019 - 05/2002
2	Pain Management 11/2023 - 01/2022
2	Therapeutics 11/2022 - 10/2016
1	Oral Administration 04/2023
1	Ligation 03/2021